EXPO Exponent Inc

Price (delayed)

$81.75

Market cap

$4.15B

P/E Ratio

38.38

Dividend/share

$1.14

EPS

$2.13

Enterprise value

$3.98B

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's interdisciplinary organization of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines ...

Highlights
The price to earnings (P/E) is 24% lower than the 5-year quarterly average of 50.0 and 18% lower than the last 4 quarters average of 46.1
The equity has grown by 18% YoY and by 2.6% from the previous quarter
EXPO's quick ratio is up by 18% year-on-year but it is down by 9% since the previous quarter
The company's debt has surged by 188% YoY

Key stats

What are the main financial stats of EXPO
Market
Shares outstanding
50.82M
Market cap
$4.15B
Enterprise value
$3.98B
Valuations
Price to earnings (P/E)
38.38
Price to book (P/B)
9.86
Price to sales (P/S)
7.48
EV/EBIT
26.99
EV/EBITDA
25.32
EV/Sales
7.12
Earnings
Revenue
$558.51M
Gross profit
$142.28M
Operating income
$119.56M
Net income
$109M
EBIT
$147.37M
EBITDA
$157.06M
Free cash flow
$137.6M
Per share
EPS
$2.13
EPS diluted
$2.11
Free cash flow per share
$2.69
Book value per share
$8.29
Revenue per share
$10.92
TBVPS
$15.03
Balance sheet
Total assets
$777.27M
Total liabilities
$356.2M
Debt
$81.48M
Equity
$421.07M
Working capital
$283.7M
Liquidity
Debt to equity
0.19
Current ratio
2.74
Quick ratio
2.58
Net debt/EBITDA
-1.13
Margins
EBITDA margin
28.1%
Gross margin
25.5%
Net margin
19.5%
Operating margin
21.4%
Efficiency
Return on assets
15.2%
Return on equity
27.3%
Return on invested capital
34.8%
Return on capital employed
24%
Return on sales
26.4%
Dividend
Dividend yield
1.39%
DPS
$1.14
Payout ratio
53.5%

EXPO stock price

How has the Exponent stock price performed over time
Intraday
1.2%
1 week
1.67%
1 month
-3.44%
1 year
1.79%
YTD
-8.25%
QTD
0.85%

Financial performance

How have Exponent's revenue and profit performed over time
Revenue
$558.51M
Gross profit
$142.28M
Operating income
$119.56M
Net income
$109M
Gross margin
25.5%
Net margin
19.5%
The net income rose by 9% YoY and by 2.5% QoQ
The company's operating income rose by 8% QoQ and by 7% YoY
EXPO's gross profit is up by 6% from the previous quarter and by 4.8% YoY
The company's operating margin rose by 5% QoQ and by 3.4% YoY

Growth

What is Exponent's growth rate over time

Valuation

What is Exponent stock price valuation
P/E
38.38
P/B
9.86
P/S
7.48
EV/EBIT
26.99
EV/EBITDA
25.32
EV/Sales
7.12
The price to earnings (P/E) is 24% lower than the 5-year quarterly average of 50.0 and 18% lower than the last 4 quarters average of 46.1
EXPO's EPS is up by 9% year-on-year and by 2.4% since the previous quarter
The P/B is 26% below the 5-year quarterly average of 13.1 and 19% below the last 4 quarters average of 12.0
The equity has grown by 18% YoY and by 2.6% from the previous quarter
The price to sales (P/S) is 27% lower than the 5-year quarterly average of 10.1 and 17% lower than the last 4 quarters average of 8.9
The revenue has grown by 4.1% YoY and by 2.5% from the previous quarter

Efficiency

How efficient is Exponent business performance
The company's return on invested capital fell by 13% YoY and by 6% QoQ
EXPO's ROA is down by 8% YoY and by 2.6% from the previous quarter
EXPO's return on sales is up by 4.3% year-on-year
Exponent's return on equity has decreased by 4.2% YoY

Dividends

What is EXPO's dividend history
DPS
$1.14
Dividend yield
1.39%
Payout ratio
53.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Exponent financials performed over time
EXPO's total assets is 118% greater than its total liabilities
The company's total liabilities rose by 23% YoY and by 7% QoQ
EXPO's total assets is up by 20% year-on-year and by 4.5% since the previous quarter
The company's debt is 81% lower than its equity
The company's debt has surged by 188% YoY
The debt to equity has surged by 138% year-on-year but it has declined by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.